STAT3 and glioblastoma: The role of the IL-6-Stat3-ODZ1 axis was further confirmed by using the neutralizing IL-6 receptor antibody which decreased the promoter activity in GBM cells cocultured with U937 cells but also the activity of the mutated promoter.